Stockscreener 앱 받기
6.41
0.63%
0.04
시간 외 거래:
6.59
0.18
+2.81%
전일 마감가:
$6.37
열려 있는:
$6.3
하루 거래량:
30,729
Relative Volume:
0.41
시가총액:
$64.86M
수익:
$2.09M
순이익/손실:
$-5.28M
주가수익비율:
-9.5672
EPS:
-0.67
순현금흐름:
$-3.64M
1주 성능:
+9.76%
1개월 성능:
+18.70%
6개월 성능:
+20.94%
1년 성능:
+83.67%
1일 변동 폭
$6.1639
$6.55
1주일 범위
$5.419
$8.11
52주 변동 폭
$3.35
$11.78
Nutriband Inc Stock (NTRB) Company Profile
명칭
Nutriband Inc
전화
407 377-6695
주소
121 S. ORANGE AVE., ORLANDO
NTRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
6.41 | 64.86M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-22 | 개시 | Noble Capital Markets | Outperform |
Nutriband Inc 주식(NTRB)의 최신 뉴스
Nutriband (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting Milestones, Commercialization Goals - Barchart.com
Examining Nutriband Inc (NTRB) more closely is necessary - uspostnews.com
A Tale of Resilience: Nutriband Inc Amid Stock Market Turbulence - investchronicle.com
Nutriband CEO Publishes Letter to Shareholders - GlobeNewswire
Nutriband (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare - The Globe and Mail
Nutriband (NTRB) Highlights Key Milestones and Future Goals Amid - GuruFocus
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue - marketscreener.com
Nutriband CEO Publishes Letter to Shareholders | NTRB Stock News - GuruFocus
Nutriband projects strong sales for abuse-deterrent patches - Investing.com Australia
ForexTV | Small Business Resources - ForexTV
Nutriband's Revolutionary Abuse-Deterrent Patch Eyes $200M Market: CEO Details Growth Strategy - Stock Titan
Nutriband Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Nutriband Inc. Leadership Gains International Recognition for Entrepreneurial Excellence - citybuzz -
Nutriband Inc reports results for the quarter ended January 31Earnings Summary - TradingView
NutriBand Inc. SEC 10-K Report - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings? - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Big Oil Could Trim Buybacks After Price Rout - The Globe and Mail
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services - ACCESS Newswire
Is Disney Stock a Buy Now as Trump Tones Down Trade War Rhetoric? - The Globe and Mail
Nutriband (NASDAQ: NTRB): Building A Moat Around Abuse-Deterrent Drug Delivery - Barchart.com
(NTRB) Investment Report - news.stocktradersdaily.com
Nutriband (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery - The Globe and Mail
Nutriband Strengthens Intellectual Property Portfolio for Abuse-Deterrent Drug Delivery - citybuzz -
Stocks in play: BioVaxys Technology Corp - The Globe and Mail
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
Nutriband secures Macao patent for drug abuse deterrent tech - Investing.com
Revolutionary Opioid Safety Tech: Nutriband Secures 46-Country Patent Protection - Stock Titan
Nutriband Partners with Charlotte FC for Brand Visibility - TipRanks
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility - The Globe and Mail
(NTRB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M - ACCESS Newswire
UPDATENutriband Signs Associate Partnership with Charlotte FC - The Manila Times
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - Bluefield Daily Telegraph
Nutriband Inc (NTRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):